Somatostatin and its receptors involvement in sevoflurane-induced neurotoxicity: a narrative review
Yixuan Niu(Shanghai Jiao Tong University), Jia Yan(Qilu Hospital of Shandong University), Yanan Jiang(Shanghai Jiao Tong University), Zhengjie Miao(Shanghai Jiao Tong University), Chen Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jing Wang(Shanghai Jiao Tong University), Jinnan Xu(Shanghai Jiao Tong University), Linhong Zhong(Dalian Medical University), Hong Jiang(Shanghai Jiao Tong University), Chuanyu Qi(Shanghai Jiao Tong University), Tiannan Chen(Shanghai Jiao Tong University), Yanyong Cheng(Shanghai Jiao Tong University), Fan Wang(Anhui Medical University), Yi Gao(Shanghai Jiao Tong University)
Cited by 2
Related Papers
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.7k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k